Skip to Main Content

We publish recommendations and resources, together with a host of other material for the benefit of our users.

PGD and VGD templates by UKHSA are developed for a range of clinical scenarios. A summary of the processes to use and further links are provided.
SPS PGD template for supply of doxycycline for the treatment of uncomplicated genital chlamydia trachomatis, LGV and non-gonococcal/non-specific urethritis.
Advice on the use of Patient Group Directions (PGDs) to supply or administer a medication which is part of a clinical trial, study or pilot
E-learning developed by SPS in partnership with UKHSA, HEE and eLfH to support professionals who use, develop, authorise, review or update PGDs.
SPS PGD template for administering benzylpenicillin prior to transfer to secondary care in suspected bacterial meningitis or meningococcal septicaemia.
A resource collating the latest medication safety communications and publications to inform, support and inspire medication safety improvements.
SPS PGD template for supply of azithromycin for uncomplicated genital Chlamydia trachomatis, non-gonococcal/non-specific urethritis; Mycoplasma genitalium.
The SPS National Medicines Governance Do Once programme produce national Patient Group Direction (PGD) exemplar templates for local adaptation
SPS PGD template for administering diazepam solution for injection for the management of seizures by registered Paramedics and Nurses.
SPS PGD template for administering tranexamic acid injection for treatment of severe haemorrhage by registered Paramedics and Nurses.
Healthcare professionals should be aware of the risks and safe practice principles when switching insulin products.
Increased awareness and embedding processes for safer use may reduce the risk of mis-selection and harms associated with insulin use.
Implementation of national safety standards, alerts and guidance can help reduce preventable harm from insulin use.
An update on the programme's progress, including the quality improvement collaborative, wider community of practice and related outputs.
Strategies, signposting and initiatives to support healthcare professionals in delivering insulin safety improvements.
Practical guidance for safe application, monitoring, removal, disposal, documentation and storage of transdermal patches to reduce risk of medication errors.
Advice to support registered midwives in the legal administration and/or supply of P and GSL medicine, using omeprazole tablets as an example.
PGD and VGD templates by UKHSA are developed for a range of clinical scenarios. A summary of the processes to use and further links are provided.
A resource collating the latest medication safety communications and publications to inform, support and inspire medication safety improvements.
Know what medicines are in the pipeline. Understand the strategic and operational challenges for the NHS. Start planning early.
New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.
Advice on the use of Patient Group Directions (PGDs) to supply or administer a medication which is part of a clinical trial, study or pilot
E-learning developed by SPS in partnership with UKHSA, HEE and eLfH to support professionals who use, develop, authorise, review or update PGDs.
A report on the state of the pharmacy technical services workforce in the North of England
A checklist for audits and self-inspections for the holders of wholesale distribution authorisations
SPS have developed a template audit tool to support organisations in auditing aspects of PGD development and use.